Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
CLA3884 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A16615 | 28282659 | Horm Metab Res | Low Serum Sex Hormone-Binding Globulin Associated with Insulin Resistance in Men with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16623 | 28278002 | Radiology | Quantifying Abdominal Adipose Tissue and Thigh Muscle Volume and Hepatic Proton Density Fat Fraction: Repeatability and Accuracy of an MR Imaging-based, Semiautomated Analysis Method. | 2017 | Details |
| A16627 | 28276821 | Expert Rev Gastroenterol Hepatol | Current and future treatment options in non-alcoholic steatohepatitis (NASH). | 2017 | Details |
| A16632 | 28274625 | Eur J Pharmacol | APD668, a G protein-coupled receptor 119 agonist improves fat tolerance and attenuates fatty liver in high-trans fat diet induced steatohepatitis model in C57BL/6 mice. | 2017 | Details |
| A16643 | 28269075 | Annu Int Conf IEEE Eng Med Biol Soc | Early diagnosis of NAFLD-NASH transition using mid infrared spectroscopy. | 2016 | Details |
| A16645 | 28267621 | J Hepatol | Targeting hepatic macrophages to treat liver diseases. | 2017 | Details |
| A16648 | 28266626 | Sci Rep | Anordrin Eliminates Tamoxifen Side Effects without Changing Its Antitumor Activity. | 2017 | Details |
| A16649 | 28266614 | Sci Rep | A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains. | 2017 | Details |
| A16660 | 28258704 | Hepatol Res | Non-alcoholic fatty liver disease phosphoproteomics: A functional piece of the precision puzzle. | 2017 | Details |
| A16679 | 28250290 | Intern Med | The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16682 | 28249257 | Dig Dis | Therapeutic Mechanisms of Bile Acids and Nor-Ursodeoxycholic Acid in Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A16705 | 28232481 | FASEB J | Hepatic DsbA-L protects mice from diet-induced hepatosteatosis and insulin resistance. | 2017 | Details |
| A16724 | 28222828 | Nutr Res Rev | Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges. | 2017 | Details |
| A16734 | 28217260 | World J Hepatol | Robotic liver surgery is the optimal approach as bridge to transplantation. | 2017 | Details |
| A16747 | 28212052 | Radiology | Proton Density Fat Fraction Measurements at 1.5- and 3-T Hepatic MR Imaging: Same-Day Agreement among Readers and across Two Imager Manufacturers. | 2017 | Details |
| A16749 | 28211165 | Liver Int | A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD. | 2017 | Details |
| A16752 | 28209760 | Diabetes | Glucoraphanin Ameliorates Obesity and Insulin Resistance Through Adipose Tissue Browning and Reduction of Metabolic Endotoxemia in Mice. | 2017 | Details |
| A16756 | 28205519 | Nat Commun | Mitochondrial ATP transporter depletion protects mice against liver steatosis and insulin resistance. | 2017 | Details |
| A16766 | 28194019 | Cell Mol Immunol | IL-25 stimulates M2 macrophage polarization and thereby promotes mitochondrial respiratory capacity and lipolysis in adipose tissues against obesity. | 2017 | Details |
| A16770 | 28191344 | Iran Red Crescent Med J | Prediction and Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) and Identification of Its Associated Factors Using the Classification Tree Method. | 2016 | Details |
| A16778 | 28183156 | J Gastroenterol Hepatol | A model to predict the onset of non-alcoholic fatty liver disease within 2 years in elderly adults. | 2017 | Details |
| A16784 | 28178565 | Cell Metab | Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics. | 2017 | Details |
| A16789 | 28176894 | Clin Exp Gastroenterol | Autoimmune hepatitis: current challenges and future prospects. | 2017 | Details |
| A16827 | 28144388 | World J Hepatol | Hepatic structural enhancement and insulin resistance amelioration due to AT1 receptor blockade. | 2017 | Details |
| A16842 | 28132890 | Gastroenterology | Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis. | 2017 | Details |
| A16843 | 28132721 | Immunobiology | Hepatic interleukin-6 production is maintained during endotoxin tolerance and facilitates lipid accumulation. | 2017 | Details |
| A16866 | 28120721 | Curr Pharm Des | Progranulin, a New Adipokine at the Crossroads of Metabolic Syndrome, Diabetes, Dyslipidemia and Hypertension. | 2017 | Details |
| A16868 | 28119530 | Int J Obes (Lond) | Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD. | 2017 | Details |
| A16880 | 28112681 | J Clin Invest | Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance. | 2017 | Details |
| A16892 | 28108233 | J Hepatol | Murine CD103+ dendritic cells protect against steatosis progression towards steatohepatitis. | 2017 | Details |
| A16905 | 28101103 | Gastroenterol Res Pract | Albumin Binding Function: The Potential Earliest Indicator for Liver Function Damage. | 2016 | Details |
| A16908 | 28099601 | An Bras Dermatol | Psoriasis comorbidities: complications and benefits of immunobiological treatment. | 2017 | Details |
| A16912 | 28098578 | J Clin Gastroenterol | Helicobacter pylori and Risk of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. | 2019 | Details |
| A16913 | 28097795 | Liver Int | Impaired N-linked glycosylation of uptake and efflux transporters in human non-alcoholic fatty liver disease. | 2017 | Details |
| A16919 | 28092182 | Exp Biol Med (Maywood) | An estrogen receptor β-selective agonist inhibits non-alcoholic steatohepatitis in preclinical models by regulating bile acid and xenobiotic receptors. | 2017 | Details |
| A16924 | 28089627 | Clin Breast Cancer | The Relationship Between Tamoxifen-associated Nonalcoholic Fatty Liver Disease and the Prognosis of Patients With Early-stage Breast Cancer. | 2016 | Details |
| A16925 | 28089623 | Dig Liver Dis | Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease? | 2016 | Details |
| A16936 | 28084058 | J Diabetes Investig | Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice. | 2017 | Details |
| A16951 | 28077274 | Biochimie | The role and regulation of the peroxisome proliferator activated receptor alpha in human liver. | 2017 | Details |
| A16953 | 28076416 | PLoS One | The CCR2 Inhibitor Propagermanium Attenuates Diet-Induced Insulin Resistance, Adipose Tissue Inflammation and Non-Alcoholic Steatohepatitis. | 2017 | Details |
| A16982 | 28064001 | Biochim Biophys Acta Mol Cell Res | Endoplasmic reticulum-mitochondria calcium signaling in hepatic metabolic diseases. | 2017 | Details |
| A16985 | 28063221 | J Cell Physiol | Novel circulating biomarkers for non-alcoholic fatty liver disease: A systematic review. | 2017 | Details |
| A16987 | 28062946 | J Gastroenterol | Upregulated absorption of dietary palmitic acids with changes in intestinal transporters in non-alcoholic steatohepatitis (NASH). | 2017 | Details |
| A16989 | 28062263 | Magn Reson Imaging | The natural history of streptozotocin-stimulated non-alcoholic steatohepatitis mice followed by Gd-EOB-DTPA-enhanced MRI: Comparison with simple steatosis mice. | 2017 | Details |
| A16998 | 28053680 | Prz Gastroenterol | Reduction of sitting time has a positive effect on the decrease of insulin resistance in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A16999 | 28053651 | Comput Math Methods Med | The Reliability of Classification of Terminal Nodes in GUIDE Decision Tree to Predict the Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17003 | 28052629 | Liver Int | Pathology of non-alcoholic fatty liver disease. | 2017 | Details |
| A17033 | 29716685 | Acta Medica (Hradec Kralove) | SGLT-2 Inhibitors: Are They a Promising Treatment Option in T2DM Patients with NAFLD? | 2018 | Details |
| A17035 | 29511467 | Gastroenterol Hepatol Bed Bench | Changing the cause of liver cirrhosis from hepatitis B virus to fatty liver in Iranian patients. | 2017 | Details |
| A17037 | 28038359 | J Nutr Biochem | Green tea extract treatment reduces NFκB activation in mice with diet-induced nonalcoholic steatohepatitis by lowering TNFR1 and TLR4 expression and ligand availability. | 2016 | Details |
| A17050 | 28028356 | World J Gastroenterol | Sirtuins and nonalcoholic fatty liver disease. | 2016 | Details |
| A17072 | 28008583 | Exp Clin Endocrinol Diabetes | EndoBarrier Gastrointestinal Liner in Type 2 Diabetic Patients Improves Liver Fibrosis as Assessed by Liver Elastography. | 2016 | Details |
| A17083 | 27999887 | Abdom Radiol (NY) | Imaging patterns and focal lesions in fatty liver: a pictorial review. | 2017 | Details |
| A17095 | 27995401 | Dig Dis Sci | Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey. | 2016 | Details |
| A17117 | 27982761 | Radiology | Liver Stiffness in Pediatric Patients with Fatty Liver Disease: Diagnostic Accuracy and Reproducibility of Shear-Wave Elastography. | 2016 | Details |
| A17121 | 27981615 | Hepatology | Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease. | 2017 | Details |
| A17122 | 27981274 | Med Ultrason | Noninvasive quantitative estimation of hepatic steatosis by ultrasound: a comparison of the hepato-renal index and ultrasound attenuation index. | 2016 | Details |
| A17141 | 27965104 | Genomics Proteomics Bioinformatics | Identification of Risk Pathways and Functional Modules for Coronary Artery Disease Based on Genome-wide SNP Data. | 2016 | Details |
| A17145 | 27957696 | Sleep Breath | The association between continuous positive airway pressure therapy and liver disease development in obstructive sleep apnea/hypopnea syndrome patients: a nationwide population-based cohort study in Taiwan. | 2016 | Details |
| A17162 | 27939359 | Pharmacol Res | A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug? | 2016 | Details |
| A17175 | 27930988 | Biomed Pharmacother | Potential involvement of PPAR α activation in diminishing the hepatoprotective effect of fenofibrate in NAFLD: Accuracy of non- invasive panel in determining the stage of liver fibrosis in rats. | 2016 | Details |
| A17187 | 27922112 | Sci Rep | Plasma cathepsin D correlates with histological classifications of fatty liver disease in adults and responds to intervention. | 2016 | Details |
| A17189 | 27920819 | Res Pharm Sci | Co-administration of metformin and N-acetylcysteine with dietary control improves the biochemical and histological manifestations in rats with non-alcoholic fatty liver. | 2016 | Details |
| A17202 | 27916647 | Biochimie | PPARs and nonalcoholic fatty liver disease. | 2016 | Details |
| A17208 | 27913996 | Dig Dis Sci | Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models. | 2016 | Details |
| A17218 | 27908400 | J Trace Elem Med Biol | Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome. | 2016 | Details |
| A17246 | 27890642 | Free Radic Biol Med | Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. | 2016 | Details |
| A17260 | 27884920 | Gut | Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity. | 2016 | Details |
| A17265 | 27880977 | Hepatology | Bariatric surgery for nonalcoholic steatohepatitis: A clinical and cost-effectiveness analysis. | 2017 | Details |
| A17283 | 27863204 | Appl Physiol Nutr Metab | TNF and IL-18 cytokines may regulate liver fat storage under homeostasis conditions. | 2016 | Details |
| A17287 | 27862719 | Hepatol Res | Development of hepatocellular carcinoma in Japanese patients with biopsy-proven non-alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progression. | 2016 | Details |
| A17294 | 27860077 | Pathol Int | Critical in vivo roles of histamine and histamine receptor signaling in animal models of metabolic syndrome. | 2016 | Details |
| A17295 | 27859643 | Congenit Anom (Kyoto) | Undernourishment in utero and hepatic steatosis in later life: A potential issue in Japanese people. | 2017 | Details |
| A17315 | 27852719 | BMJ Open | Gender differences in the association of non-alcoholic fatty liver disease and metabolic syndrome with erosive oesophagitis: a cross-sectional study in a Taiwanese population. | 2016 | Details |
| A17358 | 27825671 | Eur J Intern Med | Nonalcoholic fatty liver and the severity of acute pancreatitis. | 2016 | Details |
| A17361 | 27824421 | Dtsch Med Wochenschr | [Elevated liver enzymes]. | 2016 | Details |
| A17365 | 27822971 | Expert Opin Drug Metab Toxicol | Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue? | 2016 | Details |
| A17366 | 27822933 | J Korean Med Sci | Hemorheological Alteration in Patients Clinically Diagnosed with Chronic Liver Diseases. | 2016 | Details |
| A17370 | 27822266 | Hepat Mon | Body Roundness Index and Waist-to-Height Ratio are Strongly Associated With Non-Alcoholic Fatty Liver Disease: A Population-Based Study. | 2016 | Details |
| A17374 | 27818933 | Mol Metab | Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice. | 2016 | Details |
| A17403 | 27656762 | Gut Microbes | Hypogonadism alters cecal and fecal microbiota in male mice. | 2016 | Details |
| A17407 | 27760050 | J Clin Invest | Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance. | 2016 | Details |
| A17444 | 27718299 | J Obstet Gynaecol Res | Duration of reproductive lifespan and age at menarche in relation to metabolic syndrome in postmenopausal Chinese women. | 2016 | Details |
| A17446 | 27600089 | Eur J Clin Invest | Impact of anthropometric cut-off values in determining the prevalence of metabolic alterations. | 2016 | Details |
| A17448 | 26971094 | J Gastroenterol | Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A17457 | 27778429 | Liver Int | Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity. | 2017 | Details |
| A17460 | 27778363 | Aliment Pharmacol Ther | Review article: novel methods for the treatment of non-alcoholic steatohepatitis - targeting the gut immune system to decrease the systemic inflammatory response without immune suppression. | 2016 | Details |
| A17476 | 27693777 | Toxicol Lett | Myclobutanil worsens nonalcoholic fatty liver disease: An in vitro study of toxicity and apoptosis on HepG2 cells. | 2016 | Details |
| A17491 | 27765690 | Gastroenterology | Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes. | 2016 | Details |
| A17494 | 27724997 | Br J Nutr | Rice endosperm protein slows progression of fatty liver and diabetic nephropathy in Zucker diabetic fatty rats. | 2016 | Details |
| A17503 | 27267260 | Br Poult Sci | Dietary conjugated linoleic acid affects blood parameters, liver morphology and expression of selected hepatic genes in laying hens. | 2016 | Details |
| A17519 | 27759627 | Medicine (Baltimore) | Thiazolidinediones for nonalcoholic steatohepatitis: A meta-analysis of randomized clinical trials. | 2016 | Details |
| A17528 | 27717115 | J Sci Food Agric | Pomegranate juice prevents development of non-alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation. | 2016 | Details |
| A17548 | 27464590 | Clin Gastroenterol Hepatol | Direct and Indirect Economic Burden of Chronic Liver Disease in the United States. | 2016 | Details |
| A17567 | 27742552 | J Diabetes Complications | Non-alcoholic fatty liver disease is associated with late but not early atherosclerotic lesions in Chinese inpatients with type 2 diabetes. | 2016 | Details |
| A17577 | 27738602 | Pediatr Gastroenterol Hepatol Nutr | Associations among the Degree of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, Degree of Obesity in Children, and Parental Obesity. | 2016 | Details |
| A17581 | 27734972 | Sci Rep | Multifeature analysis of an ultrasound quantitative diagnostic index for classifying nonalcoholic fatty liver disease. | 2016 | Details |
| A17592 | 27729634 | Clin Mol Hepatol | Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment. | 2016 | Details |
| A17606 | 27721459 | Sci Rep | IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner. | 2016 | Details |
| A17607 | 27720799 | Life Sci | Deletion of exons 3 and 4 in the mouse Nr1d1 gene worsens high-fat diet-induced hepatic steatosis. | 2016 | Details |